Medline Inc. (MDLN) vs United Therapeutics Corporation (UTHR)
UTHR leads on 8 of 11 compared metrics.
A side-by-side comparison of Medline Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — MDLN vs UTHR
growth of $100 · last 1yMDLN -10.7%UTHR +9.2%UTHR compounded faster
MDLN UTHR
MDLN vs UTHR: by the numbers
- •MDLN is the larger company ($30.96B vs $23.17B market cap).
- •UTHR trades at the lower earnings multiple (20.18 vs 30.26 P/E).
- •UTHR converts more revenue to profit (40.61% vs 3.31% net margin).
Which is better, MDLN or UTHR?
Metric tally: MDLN 3 · UTHR 8It depends on what you're optimizing for:
ValueUTHR(lower P/E)
QualityUTHR(higher ROIC)
Valuation
| Metric | MDLN | UTHR |
|---|---|---|
| P/E ratio | 30.26 | 20.18● |
| Forward P/E | 22.08 | 16.48● |
| P/S ratio | 1.04● | 8.13 |
| P/B ratio | 2.68● | 4.37 |
| PEG ratio | — | 1.16 |
| EV / EBITDA | 14.87 | 14.41● |
| FCF yield | 5.05%● | 3.95% |
Profitability
| Metric | MDLN | UTHR |
|---|---|---|
| Gross margin | 24.04% | 86.58%● |
| Operating margin | 7.04% | 45.34%● |
| Net margin | 3.31% | 40.61%● |
| ROE | 8.55% | 21.82%● |
| ROIC | 5.69% | 16.14%● |
Growth (annualized)
| Metric | MDLN | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | — | 16.05% |
| EPS CAGR (5Y) | — | 20.93% |
| FCF CAGR (5Y) | — | 12.12% |
| Total return CAGR (5Y) | — | 24.96% |
Frequently asked
- Which is better, MDLN or UTHR?
- It depends on your goal. value: UTHR (lower P/E); quality: UTHR (higher ROIC). Across all compared metrics, UTHR leads 8 to 3.
- Is MDLN or UTHR cheaper?
- On trailing earnings, UTHR is cheaper: MDLN trades at a 30.26 P/E and UTHR at 20.18.
- Is MDLN or UTHR more profitable?
- UTHR runs the higher net margin — MDLN at 3.31% versus UTHR at 40.61%.
Go deeper
Dig into the metrics
Medline P/E ratioUnited Therapeutics P/E ratioMedline dividend yieldUnited Therapeutics dividend yieldMedline ROEUnited Therapeutics ROEMedline operating marginUnited Therapeutics operating marginMedline revenue growthUnited Therapeutics revenue growthMedline free cash flowUnited Therapeutics free cash flow
Medline & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 14, 2026.